EUVIMEDEUVIMED entdecken
Open Access

Bispecific GPC3/PD‑1 CAR‑T cells for the treatment of HCC

Dezhi Li, Jie Qin, Tao Zhou, Yaqin Li, Xianyi Cheng, Zaizhong Chen, Junhui Chen, Wei V Zheng

International Journal of Oncology · 10.03.2023 · 62 (4)

DOI: 10.3892/ijo.2023.5501 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Oncology, online erschienen am 10.03.2023. Verfasst von Dezhi Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Intervention and Cell Therapy Center, Peking University Shenzhen Hospital, Shenzhen, Guangdong 518036, P.R. China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit wurde bisher 51-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsHumansB7-H1 AntigenProgrammed Cell Death 1 ReceptorGlypicansT-LymphocytesTumor Microenvironment

Stichwörter der Autor:innen

cancer immunotherapychimeric antigen receptorglypican‑3hepatocellular carcinomaprogrammed death 1

Substanzen

B7-H1 AntigenProgrammed Cell Death 1 ReceptorGlypicansGPC3 protein, human

Autor:innen und Institutionen

  • Intervention and Cell Therapy Center, Peking University Shenzhen Hospital, Shenzhen, Guangdong 518036, P.R. China.
  • Department of Scientific and Research, Peking University Shenzhen Hospital, Shenzhen, Guangdong 518036, P.R. China.
  • Department of Infectious Disease, Peking University Shenzhen Hospital, Shenzhen, Guangdong 518036, P.R. China.

Zitieren

APA

Li, D., Qin, J., Zhou, T., Li, Y., Cheng, X., Chen, Z., Chen, J., & Zheng, W. V. (2023). Bispecific GPC3/PD‑1 CAR‑T cells for the treatment of HCC. International Journal of Oncology, 62(4). https://doi.org/10.3892/ijo.2023.5501

Vancouver

Li D, Qin J, Zhou T, Li Y, Cheng X, Chen Z, et al. Bispecific GPC3/PD‑1 CAR‑T cells for the treatment of HCC. International Journal of Oncology. 2023;62(4). doi:10.3892/ijo.2023.5501

BibTeX
@article{Li2023,
  author = {Li, Dezhi and Qin, Jie and Zhou, Tao and Li, Yaqin and Cheng, Xianyi and Chen, Zaizhong and Chen, Junhui and Zheng, Wei V},
  title = {Bispecific GPC3/PD‑1 CAR‑T cells for the treatment of HCC},
  journal = {International Journal of Oncology},
  year = {2023},
  volume = {62},
  number = {4},
  doi = {10.3892/ijo.2023.5501}
}
Kostenlos starten →